These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30175979)

  • 21. The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer's Disease.
    Scott XO; Stephens ME; Desir MC; Dietrich WD; Keane RW; de Rivero Vaccari JP
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping of distributions of a local b-matrix cross-term strength using diffusion tensor MRI in patients with Alzheimer's disease.
    Jahng GH; Xu S; Kim MJ
    Med Phys; 2012 Oct; 39(10):6324-31. PubMed ID: 23039668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis.
    Han W; Sapkota S; Camicioli R; Dixon RA; Li L
    Mov Disord; 2017 Dec; 32(12):1720-1728. PubMed ID: 28880465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there an MCI reversion to cognitively normal? Analysis of Alzheimer's disease biomarkers profiles.
    Park MH; Han C
    Int Psychogeriatr; 2015 Mar; 27(3):429-37. PubMed ID: 25255915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer's Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls.
    Jasbi P; Shi X; Chu P; Elliott N; Hudson H; Jones D; Serrano G; Chow B; Beach TG; Liu L; Jentarra G; Gu H
    J Proteome Res; 2021 Sep; 20(9):4303-4317. PubMed ID: 34355917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Plasma Proteins as Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease Using Liquid Chromatography-Tandem Mass Spectrometry.
    Inoue M; Suzuki H; Meno K; Liu S; Korenaga T; Uchida K
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education.
    Radanovic M; Diniz BS; Mirandez RM; Novaretti TM; Flacks MK; Yassuda MS; Forlenza OV
    Int Psychogeriatr; 2009 Dec; 21(6):1081-7. PubMed ID: 19619390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-generation biomarker discovery in Alzheimer's disease using metabolomics - from animal to human studies.
    Hurtado MO; Kohler I; de Lange EC
    Bioanalysis; 2018 Sep; 10(18):1525-1546. PubMed ID: 30198770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
    Casati M; Ferri E; Gussago C; Mazzola P; Abbate C; Bellelli G; Mari D; Cesari M; Arosio B
    Eur J Neurol; 2018 Jun; 25(6):805-810. PubMed ID: 29377401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaussian Discriminant Analysis for Optimal Delineation of Mild Cognitive Impairment in Alzheimer's Disease.
    Fang C; Li C; Cabrerizo M; Barreto A; Andrian J; Rishe N; Loewenstein D; Duara R; Adjouadi M
    Int J Neural Syst; 2018 Oct; 28(8):1850017. PubMed ID: 29793369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease.
    Mirandez RM; Aprahamian I; Talib LL; Forlenza OV; Radanovic M
    Int Psychogeriatr; 2017 Jun; 29(6):949-958. PubMed ID: 28179036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
    Landau SM; Horng A; Fero A; Jagust WJ;
    Neurology; 2016 Apr; 86(15):1377-1385. PubMed ID: 26968515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.